As of 2025-05-15, the Intrinsic Value of Shilpa Medicare Ltd (SHILPAMED.NS) is 65.81 INR. This SHILPAMED.NS valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 694.90 INR, the upside of Shilpa Medicare Ltd is -90.50%.
The range of the Intrinsic Value is 39.96 - 105.13 INR
Based on its market price of 694.90 INR and our intrinsic valuation, Shilpa Medicare Ltd (SHILPAMED.NS) is overvalued by 90.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (86.10) - (78.77) | (81.67) | -111.8% |
| DCF (Growth 10y) | 39.96 - 105.13 | 65.81 | -90.5% |
| DCF (EBITDA 5y) | 693.19 - 841.22 | 759.54 | 9.3% |
| DCF (EBITDA 10y) | 649.77 - 888.56 | 756.11 | 8.8% |
| Fair Value | 45.14 - 45.14 | 45.14 | -93.50% |
| P/E | 189.71 - 285.47 | 236.01 | -66.0% |
| EV/EBITDA | 424.96 - 664.72 | 554.52 | -20.2% |
| EPV | (62.89) - (65.69) | (64.29) | -109.3% |
| DDM - Stable | 41.63 - 79.25 | 60.44 | -91.3% |
| DDM - Multi | 102.27 - 152.42 | 122.50 | -82.4% |
| Market Cap (mil) | 67,954.27 |
| Beta | 1.15 |
| Outstanding shares (mil) | 97.79 |
| Enterprise Value (mil) | 72,688.45 |
| Market risk premium | 8.31% |
| Cost of Equity | 16.72% |
| Cost of Debt | 9.05% |
| WACC | 15.39% |